Archive for May, 2025

The MAHA Report: Make America Hallucinate Again

May 31, 2025 — Artificial intelligence sometimes produces artificial information that has no connection to reality. The term of art for this phenomenon is AI hallucinations. This week we learned that at least some parts of the MAHA report might have sprung from such hallucinations. It listed references that don’t exist and conclusions for other references that were not […]

Inflated Promises of Exercise for Fitness and a Longer Life

May 30, 2025 — To be sure, exercise has many benefits – including the widely accepted benefit of fitness and a longer life. But a new study of causal inference linking fitness to reduced mortality suggests those benefits have been exaggerated. The problem is an old one: Confounding. The senior author of the new study, Marcel Ballin, explains: “We […]

Surprise! GLP-1s Don’t Have to Blow the Bank for a Health Plan

May 29, 2025 — A new analysis from Milliman has a revelation for health plan managers complaining loudly about the burdensome costs of GLP-1s blowing up their budgets. They’re doing it wrong. Expenses for GLP-1s that can dramatically improve the health of persons with obesity simply do not have to break the bank for a health plan. In fact, […]

2019 to 2024: Obesity and Overweight Diagnoses Up by 50%

May 28, 2025 — “If you don’t have a solution for me, then it’s not a problem.” This concise statement of wisdom distilled from human behavior explains why it has been so hard for so many years to have people pay attention to obesity in any constructive way. Doctors largely ignored it and rarely diagnosed it. Patients denied it. […]

Are Health Plans Insuring Profits More Than Health?

May 27, 2025 — “It’s absolutely insane to try to keep up with it all,” says obesity medicine physician Laura Davisson. She is talking about the impossible maze of requirements that so-called health insurance plans set up to prevent people from securing coverage for medicines to treat obesity. It leads us to ask: Are health plans insuring profits more […]

From ASCO, a Hint That Obesity Treatment Prevents Cancer

May 26, 2025 — The annual meeting of the American Society of Clinical Oncology is not where we typically get insights on obesity. But from this year’s meeting, another hint emerges that treating obesity treatment may prevent some of the cancer that arises from obesity. This hint comes from a large and seemingly careful study of 170,030 persons with […]

Humility Marks the Line Between Cynicism and Skepticism

May 25, 2025 — Are we cynical? For many of us, the answer is clearly yes. News feeds give us ample reasons for general distrust of the motives of others, for thinking that self-interest is driving the actions of policymakers. Misinformation, conflicts of interest, and an apparent disregard for facts are impossible to ignore. Skepticism is certainly warranted, but […]

Implications of “Miniscule” Effects in Obesity Prevention

May 24, 2025 — In BMJ Public Health, Annabel Davies and colleagues have published a new analysis of interventions to prevent obesity in children. They started with data from two Cochrane systematic reviews published in 2024 (here and here) and applied a Bayesian multi-level meta-regression analysis. What they found were obesity prevention effects that range from being small and […]

Fear of Food and Medicine in the New MAHA Report

May 23, 2025 — The new MAHA (Making America Healthy Again) report on the health of American children is out and, in a word, things are terrible. In the words of the report, “it presents the stark reality of American children’s declining health.” We have a whole generation at risk because of toxic chemicals, ultra-processed food, unnecessary medical treatments, […]

Legal Semaglutide Compounding Ends Today, So What’s Next?

May 22, 2025 — The game is over. Today is the day legal semaglutide compounding at scale ends by decree from the FDA. Compounding pharmacies have known this day was coming since February when the agency determined that the shortage of semaglutide from Novo Nordisk was over. Well-informed patients who have depended upon compounding for affordable access to a […]